These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21766731)

  • 1. Management of unilateral versus bilateral lacrimal drainage system dysfunction in Down syndrome.
    Al-Faky YH; Mousa A; Alkhiary HT; Al-Mosallam AR
    J Pediatr Ophthalmol Strabismus; 2012; 49(2):109-13. PubMed ID: 21766731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasolacrimal outflow drainage anomalies in Down's syndrome.
    Coats DK; McCreery KM; Plager DA; Bohra L; Kim DS; Paysse EA
    Ophthalmology; 2003 Jul; 110(7):1437-41. PubMed ID: 12867406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Success rate of late primary probing in congenital nasolacrimal duct obstruction.
    Rajabi MT; Abrishami Y; Hosseini SS; Tabatabaee SZ; Rajabi MB; Hurwitz JJ
    J Pediatr Ophthalmol Strabismus; 2014; 51(6):360-2. PubMed ID: 25215516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of treatment modalities and prognostic factors in children with congenital nasolacrimal duct obstruction.
    Al-Faky YH; Al-Sobaie N; Mousa A; Al-Odan H; Al-Huthail R; Osman E; Al-Mosallam AR
    J AAPOS; 2012 Feb; 16(1):53-7. PubMed ID: 22370666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomised comparison of probing versus bicanalicular silastic intubation for congenital nasolacrimal duct obstruction.
    Al-Faky YH; Mousa A; Kalantan H; Al-Otaibi A; Alodan H; Alsuhaibani AH
    Br J Ophthalmol; 2015 Feb; 99(2):246-50. PubMed ID: 25185252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dilation probing as primary treatment for congenital nasolacrimal duct obstruction.
    Clark RA
    J AAPOS; 2002 Dec; 6(6):364-7. PubMed ID: 12506277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The results of late probing in congenital nasolacrimal duct obstruction.
    Zilelioğlu G; Hoşal BM
    Orbit; 2007 Mar; 26(1):1-3. PubMed ID: 17510863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lacrimal intubation with the Ritleng system in congenital nasolacrimal duct obstruction in children].
    Yu G; Wu Q; Lin Q; Liu W; Qi Y; Quan XJ; Cao WH; Bai DY; Zhang CY; Wang Y
    Zhonghua Yan Ke Za Zhi; 2008 Oct; 44(10):887-91. PubMed ID: 19176115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of nasolacrimal duct obstruction with probing in children younger than 4 years].
    Mrugacz M; Sielicka D; Bakunowicz-Łazarczyk A
    Klin Oczna; 2010; 112(7-9):221-2. PubMed ID: 21121125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of congenital nasolacrimal duct obstruction before and after the age of 1 year.
    Zwaan J
    Ophthalmic Surg Lasers; 1997 Nov; 28(11):932-6. PubMed ID: 9387181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Success rates of nasolacrimal duct probing at time intervals after 1 year of age.
    Robb RM
    Ophthalmology; 1998 Jul; 105(7):1307-9; discussion 1309-10. PubMed ID: 9663238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effectiveness of monocanalicular and bicanalicular silicone intubation for congenital nasolacrimal duct obstruction.
    Lee H; Ahn J; Lee JM; Park M; Baek S
    J Craniofac Surg; 2012 Jul; 23(4):1010-4. PubMed ID: 22777434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasolacrimal duct obstruction in children: outcome of intubation.
    Lim CS; Martin F; Beckenham T; Cumming RG
    J AAPOS; 2004 Oct; 8(5):466-72. PubMed ID: 15492741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Factors affected therapeutic results in treatment of children congenital nasolacrimal duct obstruction by Ritleng lacrimal intubation].
    Yu G; Hu M; Wu Q; Cao WH; Fan YW; Lin Q; Liu W
    Zhonghua Yan Ke Za Zhi; 2012 May; 48(5):423-7. PubMed ID: 22932332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonlaser endoscopic endonasal dacryocystorhinostomy with adjunctive mitomycin C in nasolacrimal duct obstruction in adults.
    Dolmetsch AM
    Ophthalmology; 2010 May; 117(5):1037-40. PubMed ID: 20079535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of lacrimal obstruction type on the efficacy of probing for congenital nasolacrimal duct obstruction].
    Zhao W; Chen LL; Xiang DM
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(35):2477-80. PubMed ID: 23158713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anatomy of probing and irrigation for congenital nasolacrimal duct obstruction.
    Zwaan J
    Ophthalmic Surg Lasers; 1997 Jan; 28(1):71-3. PubMed ID: 9031311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lacrimal intubation with the Ritleng system in recurrent congenital nasolacrimal duct obstruction in children.
    Yalaz M; Ozcan AA; Akcali C; Soylu L
    ORL J Otorhinolaryngol Relat Spec; 2004; 66(1):35-7. PubMed ID: 15103199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two endoscopically assisted procedures in primary surgical treatment of congenital nasolacrimal duct obstruction in children older than 3 years: balloon dilatation and bicanalicular silicone tube intubation.
    Ceylan K; Yuksel D; Duman S; Samim E
    Int J Pediatr Otorhinolaryngol; 2007 Jan; 71(1):11-7. PubMed ID: 16996618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silicone intubation with tissue glue anastomosis in the treatment of congenital nasolacrimal duct obstruction.
    Liao CL; Kao SC; Lin PR; Wu KC; Hou PK
    Ophthalmic Surg Lasers; 1996 Mar; 27(3):197-9. PubMed ID: 8833125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.